Leading Financial Service Provider in India | Canara Bank Securities Ltd

Alembic Pharmaceuticals Ltd.

Nov 13 BSE 1029.70 ( -17.10 -1.63%)

Volume29788

Prev. Close
1046.80

Open Price
1050.00

Today's Low / High

1024.35 1072.75

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

635.30 1072.75

Nov 13 NSE 1030.15( -17.10 -1.63%)

Volume422868

Prev. Close
1047.25

Open Price
1049.00

Today's Low / High

1024.15 1073.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

635.80 1073.00

Market Cap. ( ₹ in Cr. )	20248.95	P/BV	3.46	Book Value ( ₹ )	297.45
52 Week High/Low ( ₹ )	1073/636	FV/ML	2/1	P/E(X)	30.01
Book Closure	29/07/2026	EPS ( ₹ )	34.33	Div Yield (%)	1.16

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1965.63	1965.63	1965.63	1965.63	1965.63

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31	39.31	39.31	39.31	39.31
Total Share Capital	39.31	39.31	39.31	39.31	39.31

Reserves and Surplus	5635.50	5151.64	4778.89	4331.16	5198.23
Total Reserves and Surplus	5635.50	5151.64	4778.89	4331.16	5198.23
Total Shareholders Funds	5674.81	5190.95	4818.20	4370.47	5237.54
Minority Interest	-5.83	-1.42	0.00	0.00	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	121.92	0.00	0.00	0.00	0.00
Other Long Term Liabilities	224.94	46.77	62.88	69.23	72.14
Long Term Provisions	152.91	124.31	109.51	106.20	95.82
Total Non-Current Liabilities	499.77	171.08	172.39	175.43	167.96

CURRENT LIABILITIES
Short Term Borrowings	1238.93	1195.57	430.45	635.87	629.99
Trade Payables	835.08	879.89	735.64	679.81	706.39
Other Current Liabilities	408.62	251.00	223.65	251.19	316.51
Short Term Provisions	111.21	85.87	65.25	70.06	63.64
Total Current Liabilities	2593.84	2412.33	1454.99	1636.93	1716.53

Total Capital And Liabilities	8762.59	7772.94	6445.58	6182.83	7122.03

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2843.59	2523.53	2546.71	2398.45	1741.47
Intangible Assets	237.08	0.00	0.00	0.00	56.38
Capital Work-In-Progress	633.70	837.23	524.36	601.28	2205.79
Intangible Assets Under Development	49.70	0.00	0.00	0.00	98.44
Fixed Assets	3764.07	3360.76	3071.07	2999.73	4102.08
Non-Current Investments	140.88	127.21	93.02	96.33	118.40
Deferred Tax Assets [Net]	269.61	166.03	169.64	123.01	5.88
Other Non-Current Assets	15.43	31.15	33.29	53.74	34.88
Total Non-Current Assets	4189.99	3685.15	3367.02	3272.81	4261.24


CURRENT ASSETS
Inventories	2510.64	2288.14	1643.54	1475.27	1609.70
Trade Receivables	1466.30	1399.79	1024.84	1046.40	807.13
Cash And Cash Equivalents	202.70	90.10	126.57	82.27	69.43
OtherCurrentAssets	392.96	309.76	283.61	306.08	374.53
Total Current Assets	4572.60	4087.79	3078.56	2910.02	2860.79

Total Assets	8762.59	7772.94	6445.58	6182.83	7122.03

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	351.90	189.48	183.13	317.96	228.15

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	27.71	25.72	68.61	71.20	63.69

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	2.00
No. of Equity Shares (in Lacs)	1965.63

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31
Total Share Capital	39.31
Reserves and Surplus	5635.50
Total Reserves and Surplus	5635.50
Total Shareholders Funds	5674.81
Minority Interest	-5.83
NON-CURRENT LIABILITIES
Long Term Borrowings	121.92
Other Long Term Liabilities	224.94
Long Term Provisions	152.91
Total Non-Current Liabilities	499.77
CURRENT LIABILITIES
Short Term Borrowings	1238.93
Trade Payables	835.08
Other Current Liabilities	408.62
Short Term Provisions	111.21
Total Current Liabilities	2593.84
Total Capital And Liabilities	8762.59
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2843.59
Intangible Assets	237.08
Capital Work-In-Progress	633.70
Intangible Assets Under Development	49.70
Fixed Assets	3764.07
Non-Current Investments	140.88
Deferred Tax Assets [Net]	269.61
Other Non-Current Assets	15.43
Total Non-Current Assets	4189.99
CURRENT ASSETS
Inventories	2510.64
Trade Receivables	1466.30
Cash And Cash Equivalents	202.70
OtherCurrentAssets	392.96
Total Current Assets	4572.60
Total Assets	8762.59
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	351.90
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	27.71

Markets

Balance Sheet

BALANCE SHEET

Alembic Pharmaceuticals Ltd.